Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s share price fell 10.9% during trading on Thursday . The company traded as low as $0.55 and last traded at $0.55. 13,834 shares changed hands during trading, an increase of 361% from the average session volume of 3,001 shares. The stock had previously closed at $0.62.
Starpharma Stock Up 8.9 %
The firm has a 50-day moving average price of $0.67 and a 200-day moving average price of $0.64. The company has a debt-to-equity ratio of 0.07, a quick ratio of 4.58 and a current ratio of 4.94.
Starpharma Company Profile
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Featured Articles
- Five stocks we like better than Starpharma
- Want to Profit on the Downtrend? Downtrends, Explained.
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How to Calculate Return on Investment (ROI)
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- What is the Nikkei 225 index?
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
